INDUSTRY NEWS
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology
BioTime, Inc. announced that it has organized a new subsidiary, OrthoCyte Corporation, for the purpose of developing novel therapeutics based on stem cell technology for the treatment of injuries and disorders affecting the musculoskeletal system, including therapeutics that would regenerate bone, cartilage, tendons and ligaments. [BioTime, Inc. Press Release]
ProFibrix and CSL Behring Enter into Fibrinogen and Thrombin Supply Agreement
ProFibrix B.V. announced that it has entered into an agreement with CSL Behring for the clinical and commercial supply of plasma-based fibrinogen and thrombin, for the manufacturing of Fibrocaps™. [ProFibrix B.V. Press Release]
U.S. Biotech Firms Line Up for Tax Credits
Starting on 21 June, many small biotech companies will be racing to take advantage of a tax credit worth up to $5 million per company and totaling $1 billion as part of the Therapeutic Discovery Project Program. [NatureNews]
CorMatrix® ECM™ Receives CE Mark for Cardiac Tissue Repair
CorMatrix® Cardiovascular announced it has received CE mark for its CorMatrix Extra Cellular Matrix (ECM) for Cardiac Tissue Repair. [PR Newswire]
NIH Approves Advanced Cell Technology’s Stem Cell Line for Federal Funding
Advanced Cell Technology, Inc. announced that human embryonic stem cell line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director National Institutes of Health (NIH). [Advanced Cell Technology, Inc. Press Release]
Companies Pledge to Make More Trial Data Public
An international organization of pharmaceutical companies has adopted new guidelines governing the publication of clinical trial results. The policy calls for the industry to publish the results of late-stage, ‘phase III’ clinical trials in peer-reviewed journals, regardless of the trials’ outcome. [NatureNews]
|
|
POLICY NEWS
The Path to Personalized Medicine
The leaders of the National Institutes of Health and the Food and Drug Administration have a shared vision of personalized medicine and the scientific and regulatory structure needed to support its growth. Together, they have been focusing on the best ways to develop new therapies and optimize prescribing by steering patients to the right drug at the right dose at the right time. [Food and Drug Administration and the National Institutes of Health, United States]
Diseased Cells Fail to Win Approval
In the latest obstacle to expanding the number of embryonic stem-cell lines eligible for U.S. federal funding, a National Institutes of Health committee has unanimously rejected dozens of cell lines carrying mutations for specific diseases. [National Institutes of Health, United States]
New Videos Reveal How NIH Identifies the Most Promising Research Applications
The National Institutes of Health’s Center for Scientific Review released a new video to show new applicants and others how NIH assesses over 80,000 grant applications each year to help find those with the most merit. [National Institutes of Health, United States]
Hospital Clinic de Barcelona Obtained the First Accreditation for Cell Therapy Research
The certification, awarded for the first time in Catalonia, allows the Hospital Clinic de Barcelona to produce drugs in gene therapy, cell therapy and tissue engineering. [Spanish Medicines Agency, Spain]
Enhancing Peer Review: Advance Notice on Post-Submission Application Materials for NIH Training and Related Applications (NOT-OD-10-104) [National Institutes of Health, United States]
PFINDR: Phenotype Finder IN Data Resources: A Tool to Support Cross-study Data Discovery Among NHLBI Genomic Studies (UH2/UH3) (RFA-HL-11-020) [National Institutes of Health, United States]
Roster of the Cellular, Tissue and Gene Therapies Advisory Committee [Center for Biologics Evaluation and Research, United States]
|
|
|
EVENTS
5th International Conference on Times of Polymers (TOP) & Composites
June 20-23, 2010
Ischia, Italy
4th Annual Seminar — Key Issues for Commercialization in Regenerative Medicine
June 23, 2010
Edinburgh, Scotland
21st Meeting of the European Association for Cancer Research (EACR)
June 26-29, 2010
Oslo, Norway
UK Society for Biomaterials Annual Conference
July 1-2, 2010
Glasgow, Scotland
United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom
Regenerative Medicine Iasi (ReMedIs) 2010
July 15-18, 2010
Iasi, Romania
The Tissue & Cell Engineering Society 2010 Meeting
July 28-30, 2010
Manchester, United Kingdom
2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010
Singapore
2010 World Cancer Congress
August 18-21, 2010
Shenzhen, China
The European Molecular Biology Organization (EMBO) Meeting – Advancing the Life Sciences
September 4-7, 2010
Barcelona, Spain
23rd European Conference on Biomaterials
September 11-15, 2010
Tampere, Finland
Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States
Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia
15th Congress of the European Society of Surgical Oncology (ESSO)
September 15-17, 2010
Bordeaux, France
9th Annual Human Proteome Organization (HUPO) World Congress
September 19-23, 2010
Sydney, Australia
Symposium on Advanced Wound Care
September 23-25, 2010
Anaheim, United States
4th International Conference on Biofabrication
October 4-6, 2010
Philadelphia, United States
35th European Society for Medical Oncology (ESMO) Congress
October 8-12, 2010
Milan, Italy
BioStar 2010 – 4th Congress on Regenerative Biology and Medicine
October 13-15, 2010
Stuttgart, Germany
American Society for Matrix Biology (ASMB) 2010 Biennial Meeting
October 24-27, 2010
Charleston, United States
Select Biosciences 2nd Annual Lab-on-a-Chip World Congress
October 28-29, 2010
San Diego, United States
Fraunhofer Life Science Symposium 2010
October 29-30, 2010
Leipzig, Germany
6th National Cancer Research Institute (NCRI) Conference
November 7-10, 2010
Liverpool, United Kingdom
Select Biosciences 2nd International Forum on Stem Cells (2010 IFSC)
November 12-13, 2010
Tianjin, China
Medica 2010
November 17-20, 2010
Dusseldorf, Germany
Translational Excellence in Regenerative Medicine – Biophysical Stimuli and Mass Transport for Tissue Development
November 18-19, 2010
Lattrop, The Netherlands
Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States
Select Biosciences 5th Annual Stem Cells World Congress
January 24-25, 2011
San Diego, United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies)
Business Development Manager Europe – Cell Therapy Products (Pall Corporation)
Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza)
Sr. Product Support and Training Specialist (CardianBCT)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
Have we missed an important article or publication in Extracellular Matrix News? Click here to submit!
|
|
|
|
